HSV may enter tumor cells through herpesvirus entry mediator or Nectin (Yu et al., 2005), which are overexpressed in cancer cells, especially melanoma, or it can be designed to bind integrins highly expressed on tumor cells (You et al., 2001). Here, NECTIN1 is linked to neoplasm.